[go: up one dir, main page]

DK365282A - Fremgangsmaade til fremstilling af et kombinationspraeparat - Google Patents

Fremgangsmaade til fremstilling af et kombinationspraeparat Download PDF

Info

Publication number
DK365282A
DK365282A DK365282A DK365282A DK365282A DK 365282 A DK365282 A DK 365282A DK 365282 A DK365282 A DK 365282A DK 365282 A DK365282 A DK 365282A DK 365282 A DK365282 A DK 365282A
Authority
DK
Denmark
Prior art keywords
units
controlled release
active substance
coating
preparing
Prior art date
Application number
DK365282A
Other languages
English (en)
Other versions
DK152744C (da
DK152744B (da
Inventor
Stig Roswall
Lene Birgitte Thorhus
Original Assignee
Benzon As Alfred
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Benzon As Alfred filed Critical Benzon As Alfred
Priority to DK365282A priority Critical patent/DK152744C/da
Priority to DE198383304583T priority patent/DE106443T1/de
Priority to AT83304583T priority patent/ATE65181T1/de
Priority to EP83304583A priority patent/EP0106443B1/en
Priority to DE8383304583T priority patent/DE3382341D1/de
Priority to AU17854/83A priority patent/AU1785483A/en
Priority to CA000434484A priority patent/CA1218305A/en
Priority to FI832909A priority patent/FI832909A/fi
Priority to NO832895A priority patent/NO832895L/no
Priority to JP58148684A priority patent/JPS5962521A/ja
Priority to US06/523,635 priority patent/US4574080A/en
Publication of DK365282A publication Critical patent/DK365282A/da
Publication of DK152744B publication Critical patent/DK152744B/da
Application granted granted Critical
Publication of DK152744C publication Critical patent/DK152744C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK365282A 1982-08-13 1982-08-13 Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat DK152744C (da)

Priority Applications (11)

Application Number Priority Date Filing Date Title
DK365282A DK152744C (da) 1982-08-13 1982-08-13 Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
DE198383304583T DE106443T1 (de) 1982-08-13 1983-08-09 Pharmazeutische orale formulierung mit mehrfachen einheiten, mit kontrollierter freisetzung.
AT83304583T ATE65181T1 (de) 1982-08-13 1983-08-09 Pharmazeutische orale formulierung mit mehrfachen einheiten, mit kontrollierter freisetzung.
EP83304583A EP0106443B1 (en) 1982-08-13 1983-08-09 Pharmaceutical oral-controlled release multiple-units formulation
DE8383304583T DE3382341D1 (de) 1982-08-13 1983-08-09 Pharmazeutische orale formulierung mit mehrfachen einheiten, mit kontrollierter freisetzung.
AU17854/83A AU1785483A (en) 1982-08-13 1983-08-10 Slow release and fast release tablet formulation comprising two active ingredients
CA000434484A CA1218305A (en) 1982-08-13 1983-08-12 Combination formulation
FI832909A FI832909A (fi) 1982-08-13 1983-08-12 Farmaceutisk kombinationspreparat och foerfarande foer framstaellning daerav
NO832895A NO832895L (no) 1982-08-13 1983-08-12 Fremgangsmaate for fremstilling av et farmasoeytisk preparat med regulert frigivning av aktiv substans
JP58148684A JPS5962521A (ja) 1982-08-13 1983-08-13 医薬用の経口放出調整複合単位製剤とその製法
US06/523,635 US4574080A (en) 1982-08-13 1983-08-15 Combination formulation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK365282A DK152744C (da) 1982-08-13 1982-08-13 Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
DK365282 1982-08-13

Publications (3)

Publication Number Publication Date
DK365282A true DK365282A (da) 1984-02-14
DK152744B DK152744B (da) 1988-05-09
DK152744C DK152744C (da) 1988-10-31

Family

ID=8125282

Family Applications (1)

Application Number Title Priority Date Filing Date
DK365282A DK152744C (da) 1982-08-13 1982-08-13 Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat

Country Status (10)

Country Link
US (1) US4574080A (da)
EP (1) EP0106443B1 (da)
JP (1) JPS5962521A (da)
AT (1) ATE65181T1 (da)
AU (1) AU1785483A (da)
CA (1) CA1218305A (da)
DE (2) DE106443T1 (da)
DK (1) DK152744C (da)
FI (1) FI832909A (da)
NO (1) NO832895L (da)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
DE3305935C2 (de) * 1983-02-21 1985-05-30 Medice Chem.-Pharm. Fabrik Pütter GmbH & Co KG, 5860 Iserlohn Kaliumneutrales Saluretikum mit antihypertensiver Wirkung
JPH0759499B2 (ja) * 1984-02-10 1995-06-28 ベンツォン ファーマ エイ／エス 拡散被覆された複合単位服用剤
NL8401362A (nl) * 1984-04-27 1985-11-18 Tno Werkwijze voor het met een polymeer omhullen van deeltjesvormige materialen teneinde de gereguleerde afgifte van deze materialen aan de omgeving mogelijk te maken alsmede aldus verkregen omhuld deeltjesvormig materiaal.
JPS618A (ja) * 1984-06-09 1986-01-06 Sawai Seiyaku Kk ニフエジピン含有製剤
DE3431861A1 (de) * 1984-08-30 1986-03-13 Troponwerke GmbH & Co KG, 5000 Köln Pellet-zubereitung
DE3500103C2 (de) * 1985-01-04 1987-01-22 R.P. Scherer GmbH, 6930 Eberbach Pharmazeutische Zubereitung mit einem in Wasser und Verdauungssäften schwer löslichen Wirkstoff
US5229132A (en) * 1985-02-22 1993-07-20 Grimberg Georges Serge Non-absorbable gastrointestinal medicament provided for treating the two levels of the digestive tract at the same time
NL8500724A (nl) * 1985-03-13 1986-10-01 Univ Groningen Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
US4822619A (en) * 1987-02-18 1989-04-18 Ionor, Inc. Controlled release pharmaceutical preparation containing a gastrointestinal irritant drug
DE3814532A1 (de) * 1988-04-29 1989-11-09 Bayer Ag Dhp-retard-zubereitung
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
DE3941703C2 (de) * 1989-12-18 2002-11-07 Sanol Arznei Schwarz Gmbh Bumetanid enthaltende pharmazeutische Zubereitung
ATE118345T1 (de) * 1990-08-07 1995-03-15 Pfizer Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
US5252337A (en) * 1991-06-25 1993-10-12 Eurand America, Inc. Controlled release calcium channel blocker microcapsules
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
JP2835796B2 (ja) * 1992-02-06 1998-12-14 メルク・ジヤパン株式会社 新規な薄片状顔料
DE69327745T2 (de) * 1992-05-29 2000-09-21 Nikken Chemicals Co., Ltd. Tablette zur langsamen Freisetzung von Natriumvalproat
US5422122A (en) * 1992-08-04 1995-06-06 Eurand America, Incorporated Controlled release potassium chloride tablet
US5397574A (en) * 1993-10-04 1995-03-14 Andrx Pharmaceuticals, Inc. Controlled release potassium dosage form
US6149953A (en) * 1993-11-08 2000-11-21 Delta Food Group, Inc. Seeded microcapsules
BE1009257A3 (nl) * 1995-03-21 1997-01-07 Universiteit Gent Lab Voor Far Farmaceutische matrix.
US5674529A (en) * 1995-06-06 1997-10-07 Church & Dwight Co., Inc. Alkalinizing potassium salt controlled release preparations
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
AU6310898A (en) * 1997-03-14 1998-10-12 Toray Industries, Inc. Sustained-release prostaglandin i derivative preparation
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US20020054911A1 (en) * 2000-05-11 2002-05-09 Boehringer Mannheim Pharmaceutical Corporation-Sm Ithkline Beckman Corporation, Limited Partnershi Novel oral dosage form for carvedilol
JPH11269064A (ja) * 1998-03-20 1999-10-05 Kowa Co 胃・十二指腸付着性医薬組成物
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
DE19921549A1 (de) * 1999-05-11 2000-11-16 Merck Patent Gmbh Mahlhilfsmittel für die Röntgenfluoreszenzanalyse
US6428809B1 (en) * 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
SE9903236D0 (sv) * 1999-09-10 1999-09-10 Astra Ab Method to obtain microparticles
US20060159756A1 (en) * 1999-09-10 2006-07-20 Brita Sjoblom Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor
ES2287126T3 (es) 2000-04-27 2007-12-16 Verion Inc. Microcapsulas de liberacion de orden cero y controladas por la temperatura y procedimiento para su preparacion.
US6958161B2 (en) 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
EP1545461A4 (en) * 2002-09-09 2011-06-22 Endo Pharmaceuticals Inc COMBINED ANALGESIC COMPOSITION WITH IMMEDIATE AND PROLONGED RELEASE
US7259186B2 (en) * 2002-12-17 2007-08-21 Abbott Laboratories Salts of fenofibric acid and pharmaceutical formulations thereof
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
ATE359777T1 (de) * 2002-12-17 2007-05-15 Abbott Gmbh & Co Kg Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
ATE399539T1 (de) * 2004-04-30 2008-07-15 Topotarget Germany Ag Histondeacetylase-inhibitor enthaltende formulierung zur zweiphasigen freisetzung
CN1960713A (zh) * 2004-05-21 2007-05-09 阿库-伯雷克技术公司 含有两个或多个单元片段的药片
CA2568542A1 (en) * 2004-05-27 2005-12-08 Dexcel Pharma Technologies Ltd. Localized controlled absorption of statins in the gastrointestinal tract for achieving high blood levels of statins
GB0423800D0 (en) 2004-10-27 2004-12-01 Orexo Ab New pharmaceutical formulations
US20080152714A1 (en) * 2005-04-08 2008-06-26 Yi Gao Pharmaceutical Formulations
AU2005338350A1 (en) * 2005-11-18 2007-05-24 Solapharm, Inc. Segmented pharmaceutical dosage forms
SI2040684T1 (sl) * 2006-07-11 2013-06-28 Lek Pharmaceuticals D.D. Večenotne tablete
US8241661B1 (en) * 2011-06-24 2012-08-14 Fuisz Richard C Biocompatible film with variable cross-sectional properties
EP2674153B1 (en) * 2012-06-14 2016-08-10 ratiopharm GmbH Oral dosage form for the immediate release of bendroflumethiazide and controlled release of a second active agent
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
CN118892463B (zh) * 2024-10-09 2025-02-11 杭州高成生物营养技术有限公司 一种氯化钾缓释微丸及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
US3873346A (en) * 1970-12-23 1975-03-25 Us Interior Process of forming self-destructing pesticidal formulations
US3909444A (en) * 1971-08-05 1975-09-30 Ncr Co Microcapsule
GB1468172A (en) * 1973-03-28 1977-03-23 Benzon As Alfred Oral drug preparations
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
FR2397840B1 (da) * 1977-07-22 1981-03-20 Cherqui Jean
DE2849494A1 (de) * 1978-11-15 1980-05-29 Voss Gunter M Verfahren zur herstellung von arzneimittel-formlingen
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
US4316884A (en) * 1979-01-25 1982-02-23 Adria Laboratories, Inc. Sustained release pharmaceutical formulation
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
JPS5911563B2 (ja) * 1980-02-27 1984-03-16 日本原子力研究所 多層構造の徐放性複合体を製造する方法
JPS56152739A (en) * 1980-04-25 1981-11-26 Tanabe Seiyaku Co Ltd Production of microcapsule
US4259315A (en) * 1980-06-13 1981-03-31 A. H. Robins Company, Inc. Controlled release potassium dosage form

Also Published As

Publication number Publication date
DK152744C (da) 1988-10-31
NO832895L (no) 1984-02-14
FI832909A0 (fi) 1983-08-12
JPS5962521A (ja) 1984-04-10
DE3382341D1 (de) 1991-08-22
DK152744B (da) 1988-05-09
US4574080A (en) 1986-03-04
EP0106443A2 (en) 1984-04-25
AU1785483A (en) 1984-02-16
CA1218305A (en) 1987-02-24
EP0106443B1 (en) 1991-07-17
JPS6238323B2 (da) 1987-08-17
FI832909A (fi) 1984-02-14
EP0106443A3 (en) 1985-11-27
ATE65181T1 (de) 1991-08-15
DE106443T1 (de) 1984-09-13

Similar Documents

Publication Publication Date Title
DK365282A (da) Fremgangsmaade til fremstilling af et kombinationspraeparat
DK28480A (da) Fremgangsmaade til fremstilling af tabletter med forsinket frigivelse af det aktive middel i hvilke tabletter frigivelseshastigheden for det aktive middel er fastlagt i forvejen
JPS57112334A (en) Particles of lipid soluble substance, composition consisting of particles and biologically active substance adsorbed with particles and their manufacture
MY101544A (en) Pharmaceutical composition for external use containing active-type vitamin d3.
FI870588A0 (fi) Menetelmä hitaasti vapauttavan kiinteän annostusmuodon valmistamiseksi
ATE46438T1 (de) Enterischer ueberzug fuer pharmazeutische verabreichungsformen.
ES553063A0 (es) Procedimiento para la produccion de fosforo rojo en polvo estabilizado
EE9700176A (et) Kuivpulbriinhalaatorites kasutatav pulber, selle valmistamismeetod, selles kasutatavad osakesed ja meetod nende valmistamiseks ning pulbri lisandi kasutamine
IL53594A (en) Biological cells comprising pharmaceutically active substances and additives controlling their release from the cells,their preparation and pharmaceutical compositions containing them
ES8402720A1 (es) Procedimiento para la obtencion de una composicion a base de estireno para revestir alimentos y medicamentos.
NO884530D0 (no) Plaster med aktive stoffer for styrt avgivelse av aktive stoffer til huden, anvendelse saavel som fremgangsmaate for styrt avgivelse av aktive stoffer til huden.
IL53596A (en) Biological cells externally modified for controlled release,in the spleen and/or liver,of pharmaceutically active substances comprised therein,their preparation and pharmaceutical compositions containing them
NO872260D0 (no) Fremgangsmaate for sliping av silisiumkarbid til pulver.
EP0171528A3 (en) Controlled release pharmaceutical preparations
DE3678643D1 (de) Partikel mit konstanter wirkstofffreisetzung.
ES531434A0 (es) Procedimiento para el recubrimiento de sustratos mediante aplicacion del recubrimiento en forma de pelicula y posterior ahornado.
HU174057B (hu) Sostav dlja pokrytij obespechivajuhhij uregulirovannuju otdachy aktivnogo vehhestva biologicheski aktivnykh preparatov i sposob poluchenija takikh preparatov s uregulirovannoj otdachej aktivnogo vehhestva
DE3678641D1 (de) Partikel mit konstanter wirkstofffreisetzung.
PL240271A1 (en) Agent against ectroparasites and method of preparation of novel derivatives of 2-/phenoxyalkyl/-imidazole constituting the active substance of the agent
PT74654A (pt) Process for the preparation of compositions in powder form containing pesticides and suitable for treatment of house hold furnishing
JPS52125630A (en) Antiperkinson drugs containing l-threo-3,4-dihydroxyphenylserine
JPS54119585A (en) Production of polymer composition containing physiologically active substance
JPS5422168A (en) Glass coating method for semiconductor element
JPS5659707A (en) Lasting antibiotic pharmaceutical and its preparation
JPS6485911A (en) Plaster

Legal Events

Date Code Title Description
PBP Patent lapsed